BofA/Merrill Lynch Starts Nevro Corp (NVRO) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Wall St gains on bright earnings, megacaps' support
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil falls back after robust EU data as Mideast tensions linger
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- Apple, PepsiCo, JetBlue fall premarket; Amazon, GM and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
Piper Jaffray Remains Bullish on Nevro (NVRO) Following 2Q Beat and Raise
August 9, 2016 8:23 AM EDTPiper Jaffray reiterated an Overweight rating on Nevro Corp (NYSE: NVRO), and raised the price target to $112.00 (from $98.00), following the company's 2Q earnings report. 2Q16 revenues were $55.4 million, primarily due to the ongoing launch of HF10 therapy in the United States. Full-year 2016 revenue guidance was... More
Nevro (NVRO) Tops Q2 EPS by 16c; Guides FY16 Revenue Above Views
August 8, 2016 4:11 PM EDTNevro (NYSE: NVRO) reported Q2 EPS of ($0.31), $0.16 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $55.4 million versus the consensus estimate of $45.11 million.
GUIDANCE:
Nevro sees FY2016 revenue of $210-220 million, versus the consensus of $188.7... More
